Comments
Loading...
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Stock, Earnings Estimates, EPS, And Revenue
Eupraxia Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 7
EPS
$-0.170
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Eupraxia Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Eupraxia Pharmaceuticals (EPRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Eupraxia Pharmaceuticals (EPRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Eupraxia Pharmaceuticals (NASDAQ:EPRX) reporting earnings?
Eupraxia Pharmaceuticals (EPRX) is scheduled to report earnings on February 7, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for Eupraxia Pharmaceuticals (NASDAQ:EPRX)?
The Actual EPS was $-0.17, which missed the estimate of $0.00.
What were Eupraxia Pharmaceuticals’s (NASDAQ:EPRX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.